JP4277135B2 - W / O / W emulsion composition - Google Patents
W / O / W emulsion composition Download PDFInfo
- Publication number
- JP4277135B2 JP4277135B2 JP2003372643A JP2003372643A JP4277135B2 JP 4277135 B2 JP4277135 B2 JP 4277135B2 JP 2003372643 A JP2003372643 A JP 2003372643A JP 2003372643 A JP2003372643 A JP 2003372643A JP 4277135 B2 JP4277135 B2 JP 4277135B2
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- emulsion
- acid ester
- polyethylene glycol
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 23
- 239000008307 w/o/w-emulsion Substances 0.000 title claims description 22
- -1 fatty acid ester Chemical class 0.000 claims description 54
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 38
- 239000000194 fatty acid Substances 0.000 claims description 38
- 229930195729 fatty acid Natural products 0.000 claims description 38
- 229920001223 polyethylene glycol Polymers 0.000 claims description 35
- 239000002202 Polyethylene glycol Substances 0.000 claims description 34
- 239000000839 emulsion Substances 0.000 claims description 32
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 claims description 8
- 229940060384 isostearyl isostearate Drugs 0.000 claims description 8
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 claims description 3
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 claims description 3
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 claims description 3
- 229940093629 isopropyl isostearate Drugs 0.000 claims description 3
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 description 26
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 18
- 150000002148 esters Chemical class 0.000 description 12
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- XDOFQFKRPWOURC-UHFFFAOYSA-N iso-octadecanoic acid Natural products CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000013112 stability test Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004581 coalescence Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- VACHUYIREGFMSP-UHFFFAOYSA-N (+)-threo-9,10-Dihydroxy-octadecansaeure Natural products CCCCCCCCC(O)C(O)CCCCCCCC(O)=O VACHUYIREGFMSP-UHFFFAOYSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- JPFGKGZYCXLEGQ-UHFFFAOYSA-N 1-(4-methoxyphenyl)-5-methylpyrazole-4-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1C(C)=C(C(O)=O)C=N1 JPFGKGZYCXLEGQ-UHFFFAOYSA-N 0.000 description 3
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- VACHUYIREGFMSP-SJORKVTESA-N 9,10-Dihydroxystearic acid Natural products CCCCCCCC[C@@H](O)[C@@H](O)CCCCCCCC(O)=O VACHUYIREGFMSP-SJORKVTESA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- 229940114069 12-hydroxystearate Drugs 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 2
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- OHBICMWIWBHMIT-UHFFFAOYSA-N hexadecan-7-yl 2-ethylhexanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(CC)CCCC OHBICMWIWBHMIT-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical group CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical group 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Colloid Chemistry (AREA)
Description
本発明は、長期間の乳化安定性及び内水相成分の漏洩防止に優れたW/O/W型エマルション組成物に関する。 The present invention relates to a W / O / W emulsion composition excellent in long-term emulsification stability and prevention of leakage of inner aqueous phase components.
W/O/W型エマルション組成物は、水性成分中に油中水型エマルションを含む複合エマルション組成物である。このエマルション組成物は、W/O/W型エマルションの内水相中に様々な有用成分を内包させることにより、徐放性や酸化防止などの効果をもつ機能性エマルション組成物として利用が可能であり、医薬、化粧品、食品などとして非常に有用である。W/O/W型エマルションの乳化安定性は極めて低いため、乳化安定性を改善する方法として、ポリマーを用いて安定化する方法(特許文献1)、特定の乳化剤を用いて安定化する方法(特許文献2,3及び4)が報告されている。しかしながら、これらの方法により得られる乳化安定性より高い乳化安定性が求められているのが現状である。 The W / O / W emulsion composition is a composite emulsion composition comprising a water-in-oil emulsion in an aqueous component. This emulsion composition can be used as a functional emulsion composition having effects such as sustained release and oxidation prevention by encapsulating various useful components in the inner aqueous phase of the W / O / W emulsion. They are very useful as medicines, cosmetics, foods, and the like. Since the emulsification stability of W / O / W emulsions is extremely low, as a method for improving the emulsification stability, a method of stabilizing using a polymer (Patent Document 1), a method of stabilizing using a specific emulsifier ( Patent documents 2, 3 and 4) have been reported. However, the present situation is that the emulsion stability higher than the emulsion stability obtained by these methods is demanded.
さらに、最近では、内水相に有用成分を配合したW/O/W型エマルションを長期間保存すると、外観上安定に見えても、内水相成分が漏洩するという問題が注目されており、乳化安定性と、内水相成分の漏洩防止性を有するW/O/W型エマルションの開発が求められていた。
従って、本発明は、長期間の乳化安定性及び内水相成分の漏洩防止に優れたW/O/W型エマルション組成物の提供を目的とする。 Accordingly, an object of the present invention is to provide a W / O / W emulsion composition that is excellent in long-term emulsification stability and prevention of leakage of the inner aqueous phase component.
本発明者は、上記従来技術の問題点に鑑み鋭意検討を重ねた結果、25℃で液体の分岐または不飽和脂肪酸エステルと、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルとを含有するW/O/W型エマルション組成物が、長期間の乳化安定性及び内水相成分の漏洩防止に優れることを見出し、本発明を完成させた。 As a result of intensive studies in view of the above-mentioned problems of the prior art, the present inventor has obtained a W / O / W type containing a branched or unsaturated fatty acid ester that is liquid at 25 ° C. and a polyhydroxy fatty acid ester of polyethylene glycol. The present inventors have found that the emulsion composition is excellent in long-term emulsification stability and prevention of leakage of the inner aqueous phase component, and completed the present invention.
即ち、本発明は、下記のエマルション組成物を提供するものである。
項1.25℃で液体の分岐または不飽和脂肪酸エステルと、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルとを含有するW/O/W型エマルション組成物。
項2.分岐または不飽和脂肪酸エステルが、イソノナン酸エステル、2−エチルヘキサン酸エステル、イソステアリン酸エステル、トリイソステアリン酸エステル、テトライソステアリン酸エステルおよびオレイン酸エステルからなる群から選択される少なくとも1種のエステルである項1に記載の組成物。
項3.分岐または不飽和脂肪酸エステルが、2−エチルヘキサン酸セチル、2−エチルヘキサン酸ヘキシルデシル、イソノナン酸イソノニル、イソノナン酸イソデシル、イソノナン酸イソトリデシル、イソステアリン酸エチル、イソステアリン酸イソプロピル、イソステアリン酸ヘキシルデシル、イソステアリン酸イソステアリル、トリイソステアリン酸グリセリル、トリイソステアリン酸トリメチロールプロパン、テトライソステアリン酸ペンタエリスリトール、オレイン酸デシル、オレイン酸イソプロピルおよびオレイン酸エチルからなる群から選択される少なくとも1種のエステルである項1または2に記載の組成物。
項4.分岐または不飽和脂肪酸エステルが、イソステアリン酸イソステアリルである項1〜3のいずれかに記載の組成物。
項5.ポリエチレングリコールのポリヒドロキシ脂肪酸エステルが、ポリエチレングリコールのジポリヒドロキシ脂肪酸エステルである項1〜4のいずれかに記載の組成物。
項6.ポリエチレングリコールのポリヒドロキシ脂肪酸エステルが、ポリエチレングリコールのジポリヒドロキシステアリン酸エステルである項1〜5のいずれかに記載の組成物。
That is, the present invention provides the following emulsion composition.
Item W / O / W emulsion composition containing a branched or unsaturated fatty acid ester which is liquid at 1.25 ° C. and a polyhydroxy fatty acid ester of polyethylene glycol.
Item 2. The branched or unsaturated fatty acid ester is at least one ester selected from the group consisting of isononanoic acid ester, 2-ethylhexanoic acid ester, isostearic acid ester, triisostearic acid ester, tetraisostearic acid ester and oleic acid ester Item 2. The composition according to Item 1.
Item 3. Branched or unsaturated fatty acid ester is cetyl 2-ethylhexanoate, hexyldecyl 2-ethylhexanoate, isononyl isononanoate, isodecyl isononanoate, isotridecyl isononanoate, ethyl isostearate, isopropyl isostearate, hexyldecyl isostearate, isostearic acid Item 1 or 2 which is at least one ester selected from the group consisting of isostearyl, glyceryl triisostearate, trimethylolpropane triisostearate, pentaerythritol tetraisostearate, decyl oleate, isopropyl oleate and ethyl oleate A composition according to 1.
Item 4. Item 4. The composition according to any one of Items 1 to 3, wherein the branched or unsaturated fatty acid ester is isostearyl isostearate.
Item 5. Item 5. The composition according to any one of Items 1 to 4, wherein the polyhydroxy fatty acid ester of polyethylene glycol is a dipolyhydroxy fatty acid ester of polyethylene glycol.
Item 6. Item 6. The composition according to any one of Items 1 to 5, wherein the polyhydroxy fatty acid ester of polyethylene glycol is a dipolyhydroxystearic acid ester of polyethylene glycol.
以下、本発明を説明する。本発明のW/O/W型エマルション組成物は、25℃で液体の分岐または不飽和脂肪酸エステルと、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルとを含有することを特徴とする。 The present invention will be described below. The W / O / W emulsion composition of the present invention contains a branched or unsaturated fatty acid ester that is liquid at 25 ° C. and a polyhydroxy fatty acid ester of polyethylene glycol.
本発明の組成物において、分岐または不飽和脂肪酸エステルは、25℃で液体であれば特に制限されない。ここで、分岐または不飽和とは、脂肪酸エステルの脂肪酸部分の炭素骨格が分岐または不飽和であることを意味する。好ましいのは分岐脂肪酸モノエステルである。 In the composition of the present invention, the branched or unsaturated fatty acid ester is not particularly limited as long as it is liquid at 25 ° C. Here, the term “branched or unsaturated” means that the carbon skeleton of the fatty acid portion of the fatty acid ester is branched or unsaturated. Preference is given to branched fatty acid monoesters.
分岐または不飽和脂肪酸エステルの脂肪酸部分の炭素数は、通常6〜22、好ましくは8〜20である。不飽和脂肪酸エステルの不飽和脂肪酸部分における不飽和結合は通常1〜3個、好ましくは1個である。分岐または不飽和脂肪酸エステルの脂肪酸としては、具体的には、2−エチルヘキサン酸、イソノナン酸、イソステアリン酸、オレイン酸、リノール酸、リノレン酸を例示することができ、好ましくは、2−エチルヘキサン酸、イソノナン酸、イソステアリン酸、オレイン酸であり、より好ましくはイソステアリン酸である。 The carbon number of the fatty acid moiety of the branched or unsaturated fatty acid ester is usually 6 to 22, preferably 8 to 20. The unsaturated bond in the unsaturated fatty acid part of the unsaturated fatty acid ester is usually 1 to 3, preferably 1. Specific examples of the fatty acid of the branched or unsaturated fatty acid ester include 2-ethylhexanoic acid, isononanoic acid, isostearic acid, oleic acid, linoleic acid, and linolenic acid, and preferably 2-ethylhexane. An acid, isononanoic acid, isostearic acid, and oleic acid, more preferably isostearic acid.
分岐または不飽和脂肪酸エステルの好ましい化合物は、2−エチルヘキサン酸セチル、2−エチルヘキサン酸ヘキシルデシル、イソノナン酸イソノニル、イソノナン酸イソデシル、イソノナン酸イソトリデシル、イソステアリン酸エチル、イソステアリン酸イソプロピル、イソステアリン酸ヘキシルデシル、イソステアリン酸イソステアリル、トリイソステアリン酸グリセリル、トリイソステアリン酸トリメチロールプロパン、テトライソステアリン酸ペンタエリスリトール、オレイン酸デシル、オレイン酸イソプロピル、オレイン酸エチルなどであり、1種単独でまたは2種以上を併用して使用することができる。好ましい化合物は、イソステアリン酸イソステアリルである。 Preferred compounds of branched or unsaturated fatty acid esters are cetyl 2-ethylhexanoate, hexyldecyl 2-ethylhexanoate, isononyl isononanoate, isodecyl isononanoate, isotridecyl isononanoate, ethyl isostearate, isopropyl isostearate, hexyldecyl isostearate , Isostearyl isostearate, glyceryl triisostearate, trimethylolpropane triisostearate, pentaerythritol tetraisostearate, decyl oleate, isopropyl oleate, ethyl oleate, etc., alone or in combination of two or more Can be used. A preferred compound is isostearyl isostearate.
本発明の組成物において、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルは、ポリエチレングリコールの両端または一端に、ポリヒドロキシ脂肪酸がエステル結合した化合物である。ポリエチレングリコールのジポリヒドロキシ脂肪酸エステルはポリエチレングリコールの両端にポリヒドロキシ脂肪酸がエステル結合した化合物であり、ポリエチレングリコールのモノポリヒドロキシ脂肪酸エステルはポリエチレングリコールの一端のみにポリヒドロキシ脂肪酸がエステル結合した化合物である。好ましいのはポリエチレングリコールのジポリヒドロキシ脂肪酸エステルである。 In the composition of the present invention, the polyhydroxy fatty acid ester of polyethylene glycol is a compound in which polyhydroxy fatty acid is ester-bonded to both ends or one end of polyethylene glycol. The dipolyhydroxy fatty acid ester of polyethylene glycol is a compound in which polyhydroxy fatty acid is ester-bonded to both ends of polyethylene glycol, and the monopolyhydroxy fatty acid ester of polyethylene glycol is a compound in which polyhydroxy fatty acid is ester-bonded to only one end of polyethylene glycol. Preference is given to dipolyhydroxy fatty acid esters of polyethylene glycol.
ポリエチレングリコールのポリヒドロキシ脂肪酸エステルは、市販されているものがあり、例えばPEG-30 DIPOLYHYDROXYSTEARATE(商品名:アラセルP−135、ユニケマ社(Uniqema)製)を使用できる。また、例えばハロゲン化剤(塩化チオニル等)をポリヒドロキシ脂肪酸に反応させて得られる酸クロライドと、ポリエチレングリコールとを塩基性条件下でエステル反応させることにより得ることができる。 There are commercially available polyhydroxy fatty acid esters of polyethylene glycol. For example, PEG-30 DIPOLYHYDROXYSTEARATE (trade name: ARACEL P-135, manufactured by Uniqema) can be used. For example, it can be obtained by ester reaction of acid chloride obtained by reacting a halogenating agent (thionyl chloride or the like) with polyhydroxy fatty acid and polyethylene glycol under basic conditions.
ここで、ポリヒドロキシ脂肪酸は、ヒドロキシ脂肪酸のカルボン酸と水酸基とが縮合して得られる縮合物であり、例えば、ヒドロキシ脂肪酸をアルカリを触媒とした重縮合反応させることにより得ることができる。ポリヒドロキシ脂肪酸は、ヒドロキシ脂肪酸が2〜10個縮合したものが好ましく、3〜8個縮合したものがより好ましい。ポリヒドロキシ脂肪酸としては、ポリ(12−ヒドロキシステアリン酸)、ポリ(9,10−ジヒドロキシステアリン酸)、ポリリシノレン酸を例示することができる。 Here, the polyhydroxy fatty acid is a condensate obtained by condensing a carboxylic acid of a hydroxy fatty acid and a hydroxyl group, and can be obtained, for example, by subjecting a hydroxy fatty acid to a polycondensation reaction using an alkali as a catalyst. The polyhydroxy fatty acid is preferably one in which 2 to 10 hydroxy fatty acids are condensed, more preferably 3 to 8 condensed. Examples of the polyhydroxy fatty acid include poly (12-hydroxystearic acid), poly (9,10-dihydroxystearic acid), and polyricinolenic acid.
また、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルを構成するポリエチレングリコール部分の平均重合度は、10〜100が好ましく、20〜40がより好ましい。 Moreover, 10-100 are preferable and, as for the average polymerization degree of the polyethyleneglycol part which comprises the polyhydroxy fatty acid ester of polyethyleneglycol, 20-40 are more preferable.
ポリエチレングリコールのポリヒドロキシ脂肪酸エステルとしては、ポリエチレングリコールのモノポリ(12−ヒドロキシステアリン酸)エステルまたはジポリ(12−ヒドロキシステアリン酸)エステル、ポリエチレングリコールのモノポリ(9,10−ジヒドロキシステアリン酸)エステルまたはジポリ(9,10−ジヒドロキシステアリン酸)エステル、ポリエチレングリコールのモノポリリシノレン酸エステルまたはジポリリシノレン酸エステルなどを好ましく使用することができる。より好ましいのは、ポリエチレングリコールのモノポリ(12−ヒドロキシステアリン酸)エステルまたはジポリ(12−ヒドロキシステアリン酸)エステルであり、より一層好ましいのは、ポリエチレングリコールのジポリ(12−ヒドロキシステアリン酸)エステルである。 Polyethylene glycol polyhydroxy fatty acid esters include polyethylene glycol monopoly (12-hydroxystearic acid) ester or dipoly (12-hydroxystearic acid) ester, polyethylene glycol monopoly (9,10-dihydroxystearic acid) ester or dipoly ( 9,10-dihydroxystearic acid) ester, polyethylene glycol monopolyricinoleic acid ester or dipolyricinolenic acid ester can be preferably used. More preferred are monopoly (12-hydroxystearic acid) esters or dipoly (12-hydroxystearic acid) esters of polyethylene glycol, and even more preferred are dipoly (12-hydroxystearic acid) esters of polyethylene glycol. .
本発明のW/O/W型エマルションは、分岐または不飽和脂肪酸エステルと、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルを含有する。分岐または不飽和脂肪酸エステルの含有割合は特に制限されないが、好ましくは0.0001〜50重量%、より好ましくは0.01〜30重量%である。また、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルの含有割合は特に制限されないが、好ましくは0.00001〜10重量%、より好ましくは0.001〜5重量%である。 The W / O / W emulsion of the present invention contains a branched or unsaturated fatty acid ester and a polyhydroxy fatty acid ester of polyethylene glycol. The content of the branched or unsaturated fatty acid ester is not particularly limited, but is preferably 0.0001 to 50% by weight, more preferably 0.01 to 30% by weight. The content ratio of the polyhydroxy fatty acid ester of polyethylene glycol is not particularly limited, but is preferably 0.00001 to 10% by weight, more preferably 0.001 to 5% by weight.
次に、本発明のW/O/W型エマルション組成物の油相について説明する。油相成分としては、25℃で液体の分岐または不飽和脂肪酸エステルと、ポリエチレングリコールのポリヒドロキシ脂肪酸エステルとが含有される。その他に、本発明の効果を損なわない範囲で、例えば流動パラフィンなどの炭化水素類;25℃で液体の分岐または不飽和脂肪酸エステル以外の脂肪酸エステル類(パルミチン酸イソプロピル等);環状シリコーン、ジメチルポリシロキサンなどのシリコーン類;ジアルキルエーテル類などの油体を含んでいてもよい。また、その他の成分(脂肪、ワックス類、油溶性薬効剤、香料、顔料、乳化剤など)を含んでいてもよい。 Next, the oil phase of the W / O / W emulsion composition of the present invention will be described. As the oil phase component, a branched or unsaturated fatty acid ester which is liquid at 25 ° C. and a polyhydroxy fatty acid ester of polyethylene glycol are contained. In addition, hydrocarbons such as liquid paraffin; fatty acid esters other than branched or unsaturated fatty acid esters (such as isopropyl palmitate) that are liquid at 25 ° C .; Silicones such as siloxane; oil bodies such as dialkyl ethers may be included. In addition, other components (fats, waxes, oil-soluble medicinal agents, fragrances, pigments, emulsifiers, etc.) may be included.
脂肪の典型的な例は、グリセリド類であり、ワックスとしては、ミツロウ、パラフィンワックスなど、油溶性薬効剤としては、たとえばビタミンE、酢酸トコフェロールやアスコルビン酸のパルミチン酸エステルなどを使用できる。 Typical examples of fats are glycerides, waxes such as beeswax and paraffin wax, and oil-soluble medicinal agents such as vitamin E, tocopherol acetate and palmitic acid ester of ascorbic acid.
次に本発明のW/O/W型エマルションの内水相を説明する。油相とともに一次W/Oエマルションへと加工される内水相は、水以外に、好ましくはグリセリン、1,2−ヘキサンジオールなどのポリオール、食塩などの電解質塩類、パラベン、フェノキシエタノールなどの防腐剤、塩酸ピリドキシン、ビタミンC、グリチルリチン酸ジカリウム、植物エキス、加水分解タンパク質などの水溶性薬効剤などを含有していてよい。 Next, the inner aqueous phase of the W / O / W emulsion of the present invention will be described. The inner aqueous phase processed into a primary W / O emulsion together with the oil phase preferably contains, in addition to water, polyols such as glycerin and 1,2-hexanediol, electrolyte salts such as sodium chloride, preservatives such as paraben and phenoxyethanol, It may contain water-soluble medicinal agents such as pyridoxine hydrochloride, vitamin C, dipotassium glycyrrhizinate, plant extract, and hydrolyzed protein.
次に、本発明のW/O/W型エマルションの外水相を説明する。一次W/OエマルションW/O/W型エマルションを与える外水相は、基本的に内水相と同様の含有物質を有していてよい。具体的には、主成分の水のほかに、一般にO/Wエマルションを形成する乳化剤、さらに高分子増粘剤などが含有されていてもよい。これの代表的な例は、多糖類、とくにキサンタンガム、グアーガム、寒天、アルギン酸塩、ポリエチレングリコール、カルボキシメチルセルロースおよびヒドロキシエチルセルロース、さらに高分子量ポリエチレングリコールモノおよびジ脂肪酸エステル類、ポリアクリル酸塩、ポリビニルアルコールおよびポリビニルピロリドンなどである。また、たとえばフェノキシエタノール、パラベン類、ソルビン酸などの保存剤、香料、着色料も含有されていてよい。 Next, the outer aqueous phase of the W / O / W emulsion of the present invention will be described. The outer aqueous phase that gives the primary W / O emulsion W / O / W type emulsion may basically contain the same substances as the inner aqueous phase. Specifically, an emulsifier that generally forms an O / W emulsion, a polymer thickener, and the like may be contained in addition to the main component water. Representative examples of this are polysaccharides, especially xanthan gum, guar gum, agar, alginate, polyethylene glycol, carboxymethyl cellulose and hydroxyethyl cellulose, as well as high molecular weight polyethylene glycol mono and di fatty acid esters, polyacrylates, polyvinyl alcohol and Such as polyvinylpyrrolidone. Further, for example, preservatives such as phenoxyethanol, parabens, and sorbic acid, fragrances, and coloring agents may also be contained.
本発明のW/O/W型エマルションは、公知の方法により製造することができる。例えば以下に示すように製造する。25℃で液体の分岐または不飽和脂肪酸エステルとポリエチレングリコールのポリヒドロキシ脂肪酸エステルとその他の油相成分を、必要に応じて50〜90℃の範囲内の温度に加温し、ホモジナイザー、高圧ホモジナイザー、超音波乳化機などで撹拌しながら内水相成分を混ぜ合わせることにより、一次W/Oエマルションを調製する。油相と内水相との重量比は、好ましくは80:20〜20:80、より好ましくは60:40〜40:60である。 The W / O / W emulsion of the present invention can be produced by a known method. For example, it manufactures as shown below. A liquid branched or unsaturated fatty acid ester at 25 ° C., a polyhydroxy fatty acid ester of polyethylene glycol and other oil phase components are heated to a temperature in the range of 50 to 90 ° C. as necessary, and a homogenizer, a high-pressure homogenizer, A primary W / O emulsion is prepared by mixing the inner aqueous phase components while stirring with an ultrasonic emulsifier. The weight ratio of the oil phase to the inner aqueous phase is preferably 80:20 to 20:80, more preferably 60:40 to 40:60.
一次W/Oエマルションの調製後、これを、外水相とともに室温で攪拌してW/O/W型エマルションを調製する。一次W/Oエマルションと外水相の重量比は、好ましくは5:95〜70:30、より好ましくは5:95〜50:50である。つぎに、このエマルションを、たとえば水酸化アルカリ金属、有機酸、有機酸塩等の添加によって所望のpH値に調整してもよい。 After the preparation of the primary W / O emulsion, this is stirred with the outer aqueous phase at room temperature to prepare a W / O / W type emulsion. The weight ratio of the primary W / O emulsion to the outer aqueous phase is preferably 5:95 to 70:30, more preferably 5:95 to 50:50. Next, the emulsion may be adjusted to a desired pH value by adding an alkali metal hydroxide, an organic acid, an organic acid salt, or the like.
本発明のW/O/W型エマルション組成物は、長期間の乳化安定性及び内水相成分の漏洩防止性に優れている。このため、本発明のW/O/W型エマルションは、従来W/O/W型エマルションが使用されていた分野で使用することができる。例えば、医薬品、医薬部外品、化粧品などの分野である。より具体的には、ヘアトニック、スキャルプローション、ヘアミルク、ヘアトリートメント、ヘアコンディショナー、シャンプー、ヘアクリーム、乳液、ファンデーション、マッサージクリーム、ハンドクリーム、スキンローション、ボディーローション、ボディークリーム、フェイスクリーム、美容液などとして使用することができる。 The W / O / W emulsion composition of the present invention is excellent in long-term emulsification stability and leakage prevention of inner aqueous phase components. For this reason, the W / O / W type emulsion of the present invention can be used in a field where a conventional W / O / W type emulsion has been used. For example, it is a field of pharmaceuticals, quasi drugs, cosmetics, and the like. More specifically, hair tonic, scalp lotion, hair milk, hair treatment, hair conditioner, shampoo, hair cream, milk, foundation, massage cream, hand cream, skin lotion, body lotion, body cream, face cream, beauty liquid, etc. Can be used as
本発明のW/O/W型エマルション組成物は、長期間(例えば40℃3ヶ月)の乳化安定性及び内水相成分の漏洩防止性に優れている。このため、長期間保存後であっても、W/O/W型エマルションが有する、内水相成分の酸化防止や徐放性などを、発揮することが可能である。特にイソステアリン酸イソステアリルとポリエチレングリコールのジポリヒドロキシ脂肪酸エステルとを併用した場合に得られるW/O/W型エマルションは長期間の乳化安定性及び内水相成分の漏洩防止性に非常に優れたエマルションである。 The W / O / W emulsion composition of the present invention is excellent in long-term (for example, 3 months at 40 ° C.) emulsification stability and leakage prevention of the internal aqueous phase component. For this reason, even after long-term storage, it is possible to exhibit the antioxidant and sustained release properties of the inner aqueous phase component of the W / O / W emulsion. In particular, the W / O / W emulsion obtained when isostearyl isostearate and dipolyhydroxy fatty acid ester of polyethylene glycol are used in combination is very excellent in long-term emulsification stability and leakage prevention of internal aqueous phase components. It is an emulsion.
以下、実施例を用いて本発明を説明するが、本発明は下記実施例に限定されるものではない。なお、防腐剤にはパラベンを使用した。 EXAMPLES Hereinafter, although this invention is demonstrated using an Example, this invention is not limited to the following Example. Paraben was used as the preservative.
実施例1
(1)W/O型エマルションの製造
表1のW/Oに示した成分を使用した(表中の量は重量部を示す)。内水相成分を油相成分に混合し、高圧ホモジナイザー(1000kg/cm2)で乳化してW/O型エマルションを製造した。
(2)W/O/W型エマルションの製造
(1)で製造したW/O型エマルションを外水相成分に混合し、プロペラ攪拌機を用いて250rpmで10分間撹拌し、W/O/W型エマルションを製造した。
(3)外観安定性試験及び漏洩試験
(2)で得られたサンプルについて以下の方法で外観安定性試験及び漏洩試験を行った。試験は各サンプルの製造直後(初期)及び40℃3ヶ月放置後に行った。結果を表1に示す。
外観安定性試験
外観安定性試験は、目視による外観観察(オイル浮き)及び顕微鏡観察(エマルション粒子の観察)を行い、以下の基準により評価した。
◎:オイル浮きが全くなく、W/O/W型エマルションの合一や崩壊が認められない
○:オイル浮きはないが、W/O/W型エマルションの一部について合一又は崩壊が認められる
△:オイル浮きがややあり、W/O/W型エマルションの一部について合一について又は崩壊が認められる
×:オイル浮きがかなりあり、W/O/W型エマルションのほとんどについて合一又は崩壊が認められる
漏洩試験
各サンプルにリン酸を加えてpH2に調整した後、遠心分離(1000rpm、5分間)を行って外水相とW/Oエマルション相を分離させて外水相を分取し、分取した外水相の色差(A値)を色差計(Color Meter ZE2000(日本電色工業(株)製)により測定した。一方、外相中に食用黄色5号が全量漏洩した場合のモデルとして、表1中の外水相成分(全70重量部)に、エマルションと同量の食用黄色5号(0.001重量部)を溶解した溶液の色差(B値)を測定した。A値とB値を使用し、下記数式により漏洩率を測定し、漏洩率を使用して下記評価基準により評価した。
Example 1
(1) Production of W / O type emulsion The components shown in W / O of Table 1 were used (the amounts in the table indicate parts by weight). The inner aqueous phase component was mixed with the oil phase component and emulsified with a high-pressure homogenizer (1000 kg / cm 2 ) to produce a W / O type emulsion.
(2) Manufacture of W / O / W type emulsion The W / O type emulsion manufactured in (1) is mixed with the external water phase component and stirred for 10 minutes at 250 rpm using a propeller stirrer, W / O / W type An emulsion was prepared.
(3) Appearance stability test and leakage test The sample obtained in (2) was subjected to appearance stability test and leakage test by the following method. The test was performed immediately after the manufacture of each sample (initial stage) and after standing at 40 ° C. for 3 months. The results are shown in Table 1.
Appearance stability test The appearance stability test was performed by visual observation (oil floating) and microscopic observation (observation of emulsion particles), and evaluated according to the following criteria.
A: No oil floating, no coalescence or disintegration of W / O / W emulsion is observed. ○: No oil floating, but coalescence or disintegration is observed for a part of W / O / W emulsion. Δ: Slightly oil floating, coalescence or disintegration is observed for a part of the W / O / W type emulsion ×: Oil floating is substantial and coalescence or disintegration is observed for most of the W / O / W type emulsion Is recognized
Leakage test Each sample was adjusted to pH 2 by adding phosphoric acid, and then centrifuged (1000 rpm, 5 minutes) to separate the outer aqueous phase and the W / O emulsion phase to separate the outer aqueous phase. The color difference (A value) of the outer water phase was measured with a color meter (Color Meter ZE2000 (Nippon Denshoku Industries Co., Ltd.)). The color difference (B value) of a solution in which the same amount of edible yellow No. 5 (0.001 part by weight) as the emulsion was dissolved in the outer aqueous phase component (total 70 parts by weight) in Fig. 1 was measured. The leakage rate was measured by the following formula, and the leakage rate was used for evaluation according to the following evaluation criteria.
漏洩率(%)=100×A/B
評価基準
◎:漏洩率が10%未満
○:漏洩率が50%未満
×:漏洩率が50%以上
(4)総合評価
(3)の外観安定性試験及び漏洩試験結果を用いて下記評価基準により総合評価を行った。
Leakage rate (%) = 100 × A / B
Evaluation criteria ◎: Leakage rate is less than 10% ○: Leakage rate is less than 50% ×: Leakage rate is 50% or more (4) Comprehensive evaluation Using the appearance stability test and leak test results of (3), the following evaluation criteria A comprehensive evaluation was conducted.
総合評価基準
◎:評価結果に×が無く、◎が3個以上
○:評価結果に×が無く、◎が1または2個
×:評価結果に×がある
Comprehensive evaluation criteria ◎: No evaluation result x, 3 or more ◎ ○: No evaluation result x, 1 or 2 ◎: Evaluation result x
実施例2
表2〜4に示した成分を使用して、実施例1と同様の方法でW/O/W型エマルションを製造した。得られた各サンプルについて、実施例1と同様の方法で、外観安定性試験及び漏洩試験を行い、その結果に基づき総合評価を行った。結果を表2〜4に示す。なお、サンプル2−1〜2−15ではオイルとして25℃で液体の分岐または不飽和脂肪酸エステルを使用し、2−16〜2−21ではオイルとして直鎖脂肪酸エステル、炭化水素、25℃で固体の脂肪酸エステルなどを使用している。
Example 2
Using the components shown in Tables 2 to 4, W / O / W emulsions were produced in the same manner as in Example 1. About each obtained sample, the external stability test and the leak test were done by the same method as Example 1, and comprehensive evaluation was performed based on the result. The results are shown in Tables 2-4. In Samples 2-1 to 2-15, a branched or unsaturated fatty acid ester that is liquid at 25 ° C. is used as the oil, and in the case of 2-16 to 2-21, a linear fatty acid ester, hydrocarbon, and solid at 25 ° C. are used as the oil. The fatty acid ester etc. are used.
試験の結果、25℃で液体の分岐または不飽和脂肪酸エステルを使用することによって、他の脂肪酸エステル等を使用した場合と比較して、乳化状態が良好で内水相中の色素の漏洩が少ないことが示された。 As a result of the test, by using a liquid branched or unsaturated fatty acid ester at 25 ° C., the emulsified state is good and the leakage of the dye in the inner aqueous phase is less than when other fatty acid esters are used. It was shown that.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003372643A JP4277135B2 (en) | 2003-10-31 | 2003-10-31 | W / O / W emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003372643A JP4277135B2 (en) | 2003-10-31 | 2003-10-31 | W / O / W emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005132794A JP2005132794A (en) | 2005-05-26 |
JP4277135B2 true JP4277135B2 (en) | 2009-06-10 |
Family
ID=34648968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003372643A Expired - Lifetime JP4277135B2 (en) | 2003-10-31 | 2003-10-31 | W / O / W emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4277135B2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5220998B2 (en) * | 2006-03-14 | 2013-06-26 | サンスター株式会社 | W / O / W type skin or scalp external preparation containing liposome |
EP1985281A1 (en) * | 2007-04-26 | 2008-10-29 | Cognis IP Management GmbH | Hexyldecanol esters with short chain fatty acids |
WO2009005032A1 (en) | 2007-07-02 | 2009-01-08 | The Nisshin Oillio Group, Ltd. | W/o/w emulsion composition |
MY169271A (en) * | 2008-01-25 | 2019-03-21 | Malaysian Palm Oil Board | A method to produce polyhydroxy carboxylic acid esters of polyethylene glycol |
JP6018482B2 (en) * | 2011-12-16 | 2016-11-02 | クローダジャパン株式会社 | W / O / W emulsion composition |
JP6234112B2 (en) * | 2013-03-05 | 2017-11-22 | 株式会社ファンケル | W / O / W emulsion composition |
EP2981245B1 (en) | 2013-04-05 | 2023-03-01 | The Procter & Gamble Company | Personal care composition comprising a pre-emulsified formulation |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
MX2018008913A (en) | 2016-01-20 | 2019-05-06 | Procter & Gamble | Hair conditioning composition comprising monoalkyl glyceryl ether. |
AR121001A1 (en) * | 2020-01-10 | 2022-04-06 | Monsanto Technology Llc | HERBICIDE COMPOSITIONS INCLUDING DRIFT RETARDANT AGENTS AND METHODS OF PREPARING THE SAME |
KR102473474B1 (en) * | 2021-12-01 | 2022-12-02 | 한국콜마주식회사 | Water-in-oil-in-water type emulsion cosmetic composition and method for manufacturing thereof |
-
2003
- 2003-10-31 JP JP2003372643A patent/JP4277135B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2005132794A (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI308494B (en) | Humectant and cosmetic and external agent comprising the same | |
JP4709320B2 (en) | Method for producing O / W emulsion composition | |
JP5047369B2 (en) | Method for producing O / W fine emulsion external preparation | |
JP4277135B2 (en) | W / O / W emulsion composition | |
JP5244989B2 (en) | Method for producing O / W emulsion composition | |
KR101643261B1 (en) | Lycopene-containing composition | |
TW200413020A (en) | Vesicle dispersion and cosmetic containing the same | |
JP4093735B2 (en) | Emulsified external skin preparation | |
WO1995019762A1 (en) | Dermatologic composition | |
JP2012036102A (en) | Oil-in-water type emulsion composition and aerosol composition | |
JP2016094398A (en) | Emulsion composition | |
JP6133618B2 (en) | Water-in-oil emulsion composition | |
JP6531514B2 (en) | Emulsified composition | |
KR20140067975A (en) | Oily gel composition | |
JP5645302B2 (en) | Pharmaceutical emulsion for external use | |
JP2014196282A (en) | W/o/w type emulsion composition | |
JP2006045145A (en) | Oleaginous base and cosmetic and external preparation containing the same | |
JP4560815B2 (en) | Method for producing powdery (meth) acrylic acid copolymer, copolymer thereof, and polymer emulsifier | |
JP6850599B2 (en) | Oil-in-water emulsified composition and external preparation for skin | |
TW200916118A (en) | External preparation for skin | |
JP6001991B2 (en) | Cosmetics | |
JP2012020984A (en) | Ester derivative and cosmetic containing the ester derivative, external preparation, coating material and ink composition | |
JP2003267830A (en) | Liquid cosmetic | |
JP6018482B2 (en) | W / O / W emulsion composition | |
JP5824323B2 (en) | Water-in-oil emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060928 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080313 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081105 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090204 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090224 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120319 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4277135 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120319 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130319 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140319 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |